Project Grant R01DE034141

Award Date 7/1/24
Completion Date 4/30/29
Dollars Obligated $2M
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14214, USA
Similar Awards
This Project Grant award, funded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to investigate how the fungus Candida albicans interacts with the bacterium Streptococcus mutans to promote the formation and virulence of cariogenic biofilms. The $460,885 award, granted to the Trustees of the University of Pennsylvania, aims to identify the specific transcription factors and protein...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $3,132,562 Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) to the University of Massachusetts Lowell to develop salivary peptide/protein-based multilayer coatings for dentures to control Candida biofilm formation and prevent Candida-associated denture stomatitis. The project aims to fabricate rat dentures with the salivary anticandidal coatings, evaluate their anticandidal activity and...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $473,632 to the University of Toledo to investigate the role of megakaryocytes (MEGs) in oral and craniofacial immune responses during oropharyngeal candidiasis (OPC) caused by Candida albicans. The central hypothesis is that interleukin-17 receptor (IL-17R) signaling in MEGs is critical for mediating protection against...
This $314,000 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to gain insights into the evolution of fungal resistance in the oral environment of HIV-positive individuals. The research will leverage an existing patient dataset to: 1) use long-read sequencing to profile the fungal mycobiome in patient saliva and caries samples, and 2) perform longitudinal...
This $857,215 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate how the fungal pathogen Candida albicans adapts and causes disease in different host environments. The research aims to decipher how the fungal protein acetylation regulator GCN5 mediates niche-specific virulence of C. albicans in mouse models of oropharyngeal and invasive candidiasis. By...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $491,193 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the University of California, San Diego (UCSD) for the project "Engineering Mucin Analogues to Benefit the Mouth Environment." The project aims to create advanced mucin substitutes that closely emulate the physiological functions of natural salivary mucins, in order to develop enhanced artificial saliva...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $258,990.00 to Boston Children's Hospital to examine the role of the Candida albicans TOR1 kinase and its N-terminal heat repeats in enabling the fungal pathogen to withstand oxidative stress from the host immune system. The research aims to define the interactions between TOR1 and its N-terminal heat repeats...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $498,238 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the Research Institute at Nationwide Children's Hospital to investigate the oral microbiome in pediatric hematopoietic cell transplant patients. The grant aims to: 1) longitudinally study the impact of oral microbial species on the development and progression of oral mucositis and bloodstream infections in children...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $656,315 to Temple University to study the impact of cyclic strain on the pathogenesis of oral microbes, particularly Candida albicans and denture-related microbiota. The goal is to mechanistically understand how biomaterial cyclic strain, driven by chewing forces, can influence the virulence and dysbiosis of oral...
This federal Project Grant award in the amount of $469,830.00 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant aims to identify oral bacterial species with anti-cancer properties and evaluate their potential for preventing or treating oral squamous cell carcinoma (OSCC). Specifically, the study will assess the effects of Streptococcus mitis and Haemophilus parainfluenzae on OSCC...

SALIVARY ZINC MODIFIES HISTATIN 5 ACTIVITY TOWARDS C. ALBICANS SURVIVOR CELLS AND COMMENSALISM - CANDIDA ALBICANS IS AN OPPORTUNISTIC FUNGUS AND THE CAUSATIVE AGENT OF OROPHARYNGEAL CANDIDIASIS (OPC) THAT DEVELOPS IN A WIDE SPECTRUM OF IMMUNOCOMPROMISED PEOPLE. HOWEVER, IN HEALTHY POPULATIONS, C. ALBICANS IS A COMMENSAL ORGANISM THAT IS PART OF THE ORAL MICROBIOME. SALIVARY HISTATIN 5 (HST 5) IS A HIGHLY ABUNDANT SALIVARY PROTEIN THAT IS WELL CHARACTERIZED FOR ITS FUNGICIDAL ACTIVITY. HST 5 CONTAINS SIX HISTIDINE RESIDUES THAT COMPRISE TWO ZINC-BINDING MOTIFS. ZINC (ZN) IS THE MOST ABUNDANT SALIVARY METAL, AND ZN BINDING WITH HST 5 CAUSES OLIGOMERIZATION OF HST 5 THAT ALTERS IT FUNGICIDAL ACTIVITY. WE FOUND THAT TREATED C. ALBICANS CELLS EXPOSED TO LOW DOSES OF HST 5/ZN2+ RECOVER AS PHENOTYPICALLY DIFFERENT "SURVIVOR CELLS" THAT HAVE ALTERED CELL WALL COMPOSITION, INCREASED ADHESION AND REDUCED INVASION OF ORAL EPITHELIAL CELLS (OECS) ALONG WITH DAMPENED OEC INFLAMMATORY RESPONSES. OUR HYPOTHESIS IS THAT THE MAJOR ROLE OF SALIVARY HST 5 WHEN BOUND WITH ZINC IN VIVO IS TO PROMOTE COMMENSALISM OF ORAL C. ALBICANS THUS MAINTAINING THIS ORGANISM AS MEMBER OF THE HEALTHY ORAL MICROBIOME. WE WILL TEST OUR HYPOTHESIS WITH FOLLOWING SPECIFIC AIMS: 1. DETERMINE WHETHER CELL WALL CHANGES IN HST5-ZN INDUCED SURVIVOR CELLS MODIFY SUSCEPTIBILITY TO CELL WALL TARGETING ANTIFUNGAL DRUGS OR ALTER BINDING WITH THEIR MICROBIAL MUCOSAL BINDING PARTNERS. AIM 2. DETERMINE HOW SURVIVOR CELLS MODULATE OECS INFLAMMATORY RESPONSES AND ALTER CANDIDA COLONIZATION ALONG WITH MUCOSAL BINDING PARTNERS IN VITRO. AIM 3. TEST COMMENSALISM OF SURVIVOR CELLS IN VIVO USING A MURINE MODEL OF ORAL CANDIDIASIS BY ALTERING AMBIENT ORAL ZINC LEVELS. OUR GOAL IS TO FULLY UNDERSTAND THE HOW SALIVARY HST 5-ZN COMPLEXES MIGHT PROMOTE COMMENSALISM AND MAINTAIN A HEALTHY HOMEOSTASIS WITH MUCOSAL ORAL BINDING PARTNERS, SO THAT FUTURE CLINICAL STUDIES MIGHT BE DIRECTED TO THERAPEUTIC ORAL RINSES THAT ALTER ZINC LEVELS TO IMPROVE THE FUNCTION OF HST 5.

Posted 6/20/24, 12:00 AM